Nuo Therapeutics Stock Market Value
| AURX Stock | USD 2.15 0.15 7.50% |
| Symbol | Nuo |
Nuo Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nuo Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nuo Therapeutics.
| 11/27/2025 |
| 12/27/2025 |
If you would invest 0.00 in Nuo Therapeutics on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Nuo Therapeutics or generate 0.0% return on investment in Nuo Therapeutics over 30 days. Nuo Therapeutics is related to or competes with Kintor Pharmaceutical, Paradigm Biopharmaceutica, Hofseth BioCare, Satellos Bioscience, VitaSpring Biomedical, Imugene, and Avita Medical. Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies ... More
Nuo Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nuo Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nuo Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.47 | |||
| Information Ratio | 0.0615 | |||
| Maximum Drawdown | 59.68 | |||
| Value At Risk | (7.79) | |||
| Potential Upside | 7.98 |
Nuo Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nuo Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nuo Therapeutics' standard deviation. In reality, there are many statistical measures that can use Nuo Therapeutics historical prices to predict the future Nuo Therapeutics' volatility.| Risk Adjusted Performance | 0.0601 | |||
| Jensen Alpha | 0.5487 | |||
| Total Risk Alpha | (0.21) | |||
| Sortino Ratio | 0.0593 | |||
| Treynor Ratio | (1.02) |
Nuo Therapeutics Backtested Returns
Nuo Therapeutics appears to be dangerous, given 3 months investment horizon. Nuo Therapeutics has Sharpe Ratio of 0.055, which conveys that the firm had a 0.055 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Nuo Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Nuo Therapeutics' Risk Adjusted Performance of 0.0601, mean deviation of 4.24, and Downside Deviation of 7.47 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Nuo Therapeutics holds a performance score of 4. The company secures a Beta (Market Risk) of -0.5, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Nuo Therapeutics are expected to decrease at a much lower rate. During the bear market, Nuo Therapeutics is likely to outperform the market. Please check Nuo Therapeutics' maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Nuo Therapeutics' current price movements will revert.
Auto-correlation | -0.44 |
Modest reverse predictability
Nuo Therapeutics has modest reverse predictability. Overlapping area represents the amount of predictability between Nuo Therapeutics time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nuo Therapeutics price movement. The serial correlation of -0.44 indicates that just about 44.0% of current Nuo Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.44 | |
| Spearman Rank Test | -0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Nuo Therapeutics lagged returns against current returns
Autocorrelation, which is Nuo Therapeutics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nuo Therapeutics' otc stock expected returns. We can calculate the autocorrelation of Nuo Therapeutics returns to help us make a trade decision. For example, suppose you find that Nuo Therapeutics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nuo Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nuo Therapeutics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nuo Therapeutics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nuo Therapeutics otc stock over time.
Current vs Lagged Prices |
| Timeline |
Nuo Therapeutics Lagged Returns
When evaluating Nuo Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nuo Therapeutics otc stock have on its future price. Nuo Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nuo Therapeutics autocorrelation shows the relationship between Nuo Therapeutics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Nuo Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nuo OTC Stock Analysis
When running Nuo Therapeutics' price analysis, check to measure Nuo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuo Therapeutics is operating at the current time. Most of Nuo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nuo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuo Therapeutics' price. Additionally, you may evaluate how the addition of Nuo Therapeutics to your portfolios can decrease your overall portfolio volatility.